Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.49 |
| ▸ | MAPT | P10636 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 4/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | MITF | O75030 | 1/20 | 0.47 |
| ▸ | MC4R | P32245 | 1/20 | 0.47 |
| ▸ | HPD | P32754 | 3/20 | 0.47 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.47 |
| ▸ | AKR1C4 | P17516 | 2/20 | 0.47 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.47 |
| ▸ | AKR1C2 | P52895 | 2/20 | 0.47 |
| ▸ | AKR1C1 | Q04828 | 2/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6487344 | 1.00 | CYP1A2 (0.63) | CYP1A2ALDH1A1MAPTMEN1KMT2A | |
| SCHEMBL29500840 | 0.88 | CYP1A2 (0.51) | CYP1A2ALDH1A1MAPTMEN1KMT2A | |
| SCHEMBL10680778 | 0.87 | CYP1A2 (0.58) | CYP1A2ALDH1A1MAPTMEN1KMT2A | |
| SCHEMBL28321274 | 0.87 | CYP1A2 (0.47) | CYP1A2ALDH1A1MAPTMEN1KMT2A | |
| SCHEMBL10511895 | 0.87 | CYP1A2 (0.47) | CYP1A2ALDH1A1MAPTMEN1KMT2A | |
| SCHEMBL10511891 | 0.87 | CYP1A2 (0.47) | CYP1A2ALDH1A1MAPTMEN1KMT2A | |
| SCHEMBL2977227 | 0.87 | HPD (0.52) | CYP1A2ALDH1A1MAPTMEN1KMT2A | |
| SCHEMBL27956759 | 0.85 | ALDH1A1 (0.47) | CYP1A2ALDH1A1MAPTMEN1KMT2A | |
| SCHEMBL22688204 | 0.85 | CYP1A2 (0.63) | CYP1A2ALDH1A1MAPTCYP2C19HPGD | |
| SCHEMBL5292681 | 0.84 | MEN1 (0.51) | CYP1A2ALDH1A1MAPTMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240002368-A1 | STING ANTAGONISTS AND USES THEREOF | REGOR PHARMACEUTICALS, INC. | 2024-01-04 | — | — | US | disclosed |
| CN-111484417-B | Preparation method of halofantrine hydrochloride | 新发药业有限公司 | 2022-05-17 | — | — | CN | disclosed |
| CN-111484417-A | Preparation method of halofantrine hydrochloride | 新发药业有限公司 | 2020-08-04 | — | — | CN | disclosed |
| US-10654834-B2 | Non-systemic TGR5 agonists | Venenum Biodesign, LLC (US) | 2020-05-19 | — | — | US | disclosed |
| US-20190330191-A1 | NOVEL NON-SYSTEMIC TGR5 AGONISTS | Venenum Biodesign, LLC (US) | 2019-10-31 | — | — | US | disclosed |
| WO-2013093928-A1 | AN IMPROVED PROCESS FOR PREPARING 2-OXINDOLES OF FORMULA I, A KEY RAW MATERIAL FOR MAKING PHARMACEUTICAL DRUGS AND INTERMEDIATES THEREOF | ARCH PHARMALABS LIMITED (IN) | 2013-06-27 | — | — | WO | disclosed |
| EP-2451783-A2 | LONIDAMINE ANALOGUES FOR FERTILITY MANAGEMENT | University Of Kansas (US) | 2012-05-16 | — | — | EP | disclosed |
| WO-2011005759-A2 | LONIDAMINE ANALOGUES FOR FERTILITY MANAGEMENT | UNIVERSITY OF KANSAS (US) | 2011-01-13 | — | — | WO | disclosed |
| US-20100063301-A1 | SYNTHESIS OF THROMBOPOIETIN ACTIVITY MODULATING COMPOUNDS | LIGAND PHARMACEUTICALS INC (US) | 2010-03-11 | — | — | US | disclosed |
| CN-101437792-A | Synthesis of thrombopoietin activity modulating compounds | LIGAND PHARM INC (US) | 2009-05-20 | — | — | CN | disclosed |
| CN-1177347-A | Process for preparing 2 -oxindoles and N -hydroxy -2 -oxindoles | CATALYTICA INC (US) | 1998-03-25 | — | — | CN | disclosed |
| US-5711966-A | REPLACEMENT OF HALOFANTRINE AVOIDS CARDIAC ARRHYTHMIAS | ARMY MEDICAL RESEARCH & MATERIEL COMMAND, GOVERNMENT OF THE UNITED STATES, U.S. | 1998-01-27 | — | — | US | disclosed |
| EP-0809631-A1 | PROCESS FOR PREPARING 2-OXINDOLES AND N-HYDROXY-2-OXINDOLES | CATALYTICA, INC. (US) | 1997-12-03 | — | — | EP | disclosed |
| US-5688955-A | ANALGESICS | ADOLOR CORPORATION (US) | 1997-11-18 | — | — | US | disclosed |
| WO-1997042187-A1 | OXINDOLE DERIVATIVES | ZENECA LIMITED (GB) | 1997-11-13 | — | — | WO | disclosed |
| WO-1997032857-A1 | KAPPA AGONIST COMPOUNDS AND PHARMACEUTICAL FORMULATIONS THEREOF | ADOLOR CORPORATION (US) | 1997-09-12 | — | — | WO | disclosed |
| WO-1997007792-A1 | DESBUTYLHALOFANTRINE COMPOSITIONS AND USE | DEPARTMENT OF THE ARMY, US GOVERNMENT (US) | 1997-03-06 | — | — | WO | disclosed |
| WO-1996023770-A1 | PROCESS FOR PREPARING 2-OXINDOLES AND N-HYDROXY-2-OXINDOLES | CATALYTICA, INC. (US) | 1996-08-08 | — | — | WO | disclosed |
| EP-0162776-B1 | HETEROCYCLIC DERIVATIVES, PROCESS FOR THEIR PREPARATION AND MEDICAMENTS USEFUL AS ALDOSE REDUCTASE INHIBITORS CONTAINING THEM | LABORATOIRES UPSA (FR) | 1989-04-19 | — | — | EP | disclosed |
| EP-0162776-A2 | Heterocyclic derivatives, process for their preparation and medicaments useful as aldose reductase inhibitors containing them | LABORATOIRES UPSA (FR) | 1985-11-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190330191-A1 | NOVEL NON-SYSTEMIC TGR5 AGONISTS | GPR119, FFAR1, FFAR3 | CYP1A2 1439/4885ALDH1A1 3170/4885MAPT 3811/4885 |
| US-20100063301-A1 | SYNTHESIS OF THROMBOPOIETIN ACTIVITY MODULATING COMPOUNDS | MPL, THPO, TBXAS1 | CYP1A2 3803/4885ALDH1A1 3289/4885MAPT 4801/4885 |
| US-10654834-B2 | Non-systemic TGR5 agonists | GPR119, SSTR5, FFAR3 | CYP1A2 1241/4885ALDH1A1 3118/4885MAPT 3667/4885 |
| US-20240002368-A1 | STING ANTAGONISTS AND USES THEREOF | STING1, TBK1, CGAS | CYP1A2 4632/4885ALDH1A1 4807/4885MAPT 1002/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.